Tumor-Promoting Role of MSX1 in Cervical Cancer
In a groundbreaking study published on June 5, 2026, in Cell Death Discovery, researchers Brücker, Horn, Jansari, and colleagues have ...
In a groundbreaking study published on June 5, 2026, in Cell Death Discovery, researchers Brücker, Horn, Jansari, and colleagues have ...
In a groundbreaking study that could revolutionize treatment paradigms for some of the most lethal forms of cancer, researchers at ...
In a compelling new review published in Cancer Biology & Medicine, researchers from Nankai University, the University of Utah, and ...
At the forefront of cancer research, The University of Texas MD Anderson Cancer Center continues to pioneer transformative advances that ...
In a groundbreaking advancement for oncology, researchers have unveiled promising results from the phase Ib/II clinical trial investigating tinengotinib, a ...
In the relentless pursuit of innovative cancer therapies, scientists have unveiled a groundbreaking strategy targeting the PBX1–BCL2L1 axis as a ...
In the relentless battle against cancer, researchers have long sought to exploit the vulnerabilities within malignant cells, particularly their reliance ...
A groundbreaking first-in-human clinical trial has unveiled promising results for setidegrasib, an innovative therapeutic agent that specifically targets the KRAS ...
In a groundbreaking advance that could reshape the future of cancer treatment, researchers at Baylor College of Medicine have unveiled ...
Dr. Aditya Bardia, a prominent professor of medicine at the David Geffen School of Medicine at UCLA and the director ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine